This registry evaluated the 24-month safety and efficacy of levodopa-carbidopa intestinal gel (LCIG) treatment in advanced Parkinson's disease (PD) patients under routine clinical care
Continuous administration of levodopa-carbidopa intestinal gel (carbidopa-levodopa enteral suspensio...
INTRODUCTION: This registry evaluated the 24-month safety and efficacy of levodopa-carbidopa intesti...
INTRODUCTION: This registry evaluated the 24-month safety and efficacy of levodopa-carbidopa intesti...
Introduction This registry evaluated the 24-month safety and efficacy of levodopa-carbidopa intestin...
Introduction: This registry evaluated the 24-month safety and efficacy of levodopa-carbidopa intesti...
INTRODUCTION: This registry evaluated the 24-month safety and efficacy of levodopa-carbidopa intesti...
INTRODUCTION: This registry evaluated the 24-month safety and efficacy of levodopa-carbidopa intesti...
Background. Levodopa-carbidopa intestinal gel (LCIG) provides continuous levodopa administration and...
Background. Levodopa-carbidopa intestinal gel (LCIG) provides continuous levodopa administration and...
Introduction: The GLORIA registry included 375 advanced Parkinson’s disease (PD) patients and evalua...
© 2017, Media Sphera. All rights reserved.Objective: To evaluate the long-term safety and efficacy o...
The duration of action of oral levodopa becomes shorter as Parkinson’s disease (PD) progresses. Pati...
© 2017, Media Sphera. All rights reserved.Objective: To evaluate the long-term safety and efficacy o...
The GREENFIELD observational study assessed the effect of levodopa/carbidopa intestinal gel (LCIG) o...
Motor complications in Parkinson's disease (PD) are associated with long-term oral levodopa treatmen...
Continuous administration of levodopa-carbidopa intestinal gel (carbidopa-levodopa enteral suspensio...
INTRODUCTION: This registry evaluated the 24-month safety and efficacy of levodopa-carbidopa intesti...
INTRODUCTION: This registry evaluated the 24-month safety and efficacy of levodopa-carbidopa intesti...
Introduction This registry evaluated the 24-month safety and efficacy of levodopa-carbidopa intestin...
Introduction: This registry evaluated the 24-month safety and efficacy of levodopa-carbidopa intesti...
INTRODUCTION: This registry evaluated the 24-month safety and efficacy of levodopa-carbidopa intesti...
INTRODUCTION: This registry evaluated the 24-month safety and efficacy of levodopa-carbidopa intesti...
Background. Levodopa-carbidopa intestinal gel (LCIG) provides continuous levodopa administration and...
Background. Levodopa-carbidopa intestinal gel (LCIG) provides continuous levodopa administration and...
Introduction: The GLORIA registry included 375 advanced Parkinson’s disease (PD) patients and evalua...
© 2017, Media Sphera. All rights reserved.Objective: To evaluate the long-term safety and efficacy o...
The duration of action of oral levodopa becomes shorter as Parkinson’s disease (PD) progresses. Pati...
© 2017, Media Sphera. All rights reserved.Objective: To evaluate the long-term safety and efficacy o...
The GREENFIELD observational study assessed the effect of levodopa/carbidopa intestinal gel (LCIG) o...
Motor complications in Parkinson's disease (PD) are associated with long-term oral levodopa treatmen...
Continuous administration of levodopa-carbidopa intestinal gel (carbidopa-levodopa enteral suspensio...
INTRODUCTION: This registry evaluated the 24-month safety and efficacy of levodopa-carbidopa intesti...
INTRODUCTION: This registry evaluated the 24-month safety and efficacy of levodopa-carbidopa intesti...